Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embro Vascular is a medical technology company dedicated to advancing the field of peripheral vascular embolization. The company's core innovation is the Embro Embolization System, which provides interventional radiologists and vascular surgeons with a highly controlled method for vessel occlusion. This technology is utilized in the treatment of various clinical conditions, including hypervascular tumors, arteriovenous malformations, and acute hemorrhages. By prioritizing procedural predictability and ease of delivery, Embro Vascular seeks to improve clinical outcomes and streamline complex endovascular interventions. The company is headquartered in Florida and maintains a focus on expanding its portfolio of minimally invasive vascular solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Embro Vascular.